000 01328 a2200409 4500
005 20250513070908.0
264 0 _c19940131
008 199401s 0 0 eng d
022 _a0065-4299
024 7 _a10.1007/BF01972729
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBerger, A E
245 0 0 _aModulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470.
_h[electronic resource]
260 _bAgents and actions
_c1993
300 _aC86-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntibiotics, Antineoplastic
_xpharmacology
650 0 4 _aCells, Cultured
650 0 4 _aCyclohexanes
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_xmetabolism
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aMice
650 0 4 _aO-(Chloroacetylcarbamoyl)fumagillol
650 0 4 _aSesquiterpenes
_xpharmacology
650 0 4 _aStaphylococcal Toxoid
_xtoxicity
650 0 4 _aT-Lymphocytes
_xdrug effects
650 0 4 _aTetanus Toxin
_xtoxicity
700 1 _aDortch, K A
700 1 _aStaite, N D
700 1 _aMitchell, M A
700 1 _aEvans, B R
700 1 _aHolm, M S
773 0 _tAgents and actions
_gvol. 39 Spec No
_gp. C86-8
856 4 0 _uhttps://doi.org/10.1007/BF01972729
_zAvailable from publisher's website
999 _c8272878
_d8272878